Dianox
Copenhagen
About Dianox
Dianox is a founder-led biotech startup with an AI drug discovery platform for targeting undruggable proteins with DNA & RNA. Big opportunity as 85% of proteins are undruggable with small molecules and unreachable by antibodies. Our platform consists of the world's most powerful drug library and proprietary Deep Learning models that enable us to generate novel DNA & RNA drugs for efficient delivery to previously undruggable proteins. We can accelerate drug discovery in oncology, dermatology and ophthalmology. We believe good health is the most important aspect of life. Our company is dedicated to building better therapeutics and diagnostics to help people in their health journey. We are always on the lookout for passionate partners in the health space. If you are excited about the potential of our work, please reach out via [email protected].
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Last round: Non-Equity Assistance (Jul 2022)
- Website: dianox.com
- Phone: +45 71 20 6000
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/dianox-2414424 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.